Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptid
Kurzübersicht für Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptid (ABIN8103410)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- IRAK2 Peptide - C-terminal region
-
Sequenz
- SSSEACVGLE PPQDVTETSW QIEINEAKRK LMENILLYKE EKVDSIELFG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-IRAK2 Antibody (ARP61222_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IRAK2 (Interleukin-1 Receptor-Associated Kinase 2 (IRAK2))
-
Hintergrund
-
Background Information: IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB.
Alternative Symbols: IRAK-2, MGC150550
-
Molekulargewicht
- 69kDa
-
Gen-ID
- 3656
-
NCBI Accession
- NP_001561
-
UniProt
- O43187
Target
-